Strata Critical Medical, Inc. SRTA
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -161.43% | 311.88% | 276.90% | 251.42% | 178.49% |
| Total Depreciation and Amortization | 240.28% | 129.80% | 70.13% | 25.34% | -20.41% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 136.77% | -542.79% | -466.86% | -495.12% | -337.06% |
| Change in Net Operating Assets | -589.33% | -166.88% | -214.09% | -201.76% | 195.86% |
| Cash from Operations | 125.31% | -2,886.70% | -450.25% | -1,841.80% | -319.94% |
| Capital Expenditure | 19.52% | 33.72% | 62.77% | 68.91% | 53.16% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 42.95% | -4,445.20% | -2,883.63% | -2,883.63% | -2,822.60% |
| Divestitures | -49.80% | -- | -- | -- | -- |
| Other Investing Activities | -54.15% | 92.87% | 424.47% | 363.56% | 471.42% |
| Cash from Investing | -77.33% | -96.26% | 1,532.45% | 6,965.16% | 1,227.94% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -38.25% | 34.88% | 35.04% | 14.88% | 39.69% |
| Repurchase of Common Stock | 4.96% | 16.62% | 47.22% | -53.62% | -450.61% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.20% | 13.90% | 45.07% | -54.75% | -478.83% |
| Foreign Exchange rate Adjustments | 100.00% | -367.83% | -745.83% | -323.75% | -1,118.18% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 669.25% | -236.88% | 1,082.25% | 223.59% | 109.54% |